Nora Garcia-Flores
Acute Care · Homestead, FLNPI 1285151399
Payments from drug & device makers
Across 45 payments — averaging $53.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vifor Pharma, Inc.$836
- Amgen$357
- AstraZeneca$223
- Astellas Pharma US Inc$124
- Merck$106
- Mallinckrodt Hospital Products Inc.$100
- plus $672 from 20 others
What the payments were for
- Food & beverage$2,31796%
- Education$1004%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Vifor Pharma, Inc. | 7 | $836 |
| Amgen | 2 | $357 |
| AstraZeneca | 5 | $223 |
| Astellas Pharma US Inc | 1 | $124 |
| Merck | 4 | $106 |
| Mallinckrodt Hospital Products Inc. | 1 | $100 |
| GSK | 1 | $87 |
| Incyte Corporation | 3 | $70 |
| Daiichi Sankyo Inc. | 2 | $59 |
| Novartis | 2 | $47 |
| Jazz Pharmaceuticals Inc. | 2 | $45 |
| Sanofi-aventis U.S. LLC | 1 | $34 |
| Gilead | 1 | $34 |
| Array Biopharma Inc | 1 | $30 |
| Apellis Pharmaceuticals, Inc. | 1 | $26 |
| Sanofi | 1 | $26 |
| Geron Corporation | 1 | $25 |
| Caris MPI, Inc. | 1 | $25 |
| Stemline Therapeutics Inc. | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| Lilly USA, LLC | 1 | $23 |
| Eisai Inc. | 1 | $21 |
| Johnson & Johnson | 1 | $20 |
| Novo Nordisk | 1 | $17 |
| Beone Medicines USA, Inc. | 1 | $17 |
| Agios Pharmaceuticals, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,417 in reported general payments places this provider in the 85th percentile of 1,150 acute care providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sevelamer Carbonate | 28 | $3,947 |
| Gabapentin | 12 | $84 |
Paid to pharmacies, not to this prescriber.
Other acute care in Homestead
- Melisa WilsonOrlando$3.6M
- Amanda PeacockJacksonville$81K
- Katrina RileyTampa$66K
- Diane GrayLake Mary$49K
- Heather RamousSafety Harbor$38K
- Melanie WeresJacksonville$37K
- Jayne JaramilloJacksonville$27K
- Melissa HamiltonTampa$23K
- Kimberly GrantAltamonte Springs$20K
- Julie ElliottWinter Haven$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.